The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.

Drugmaker Eli Lilly and Co. says it'll build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands ...

Feb 3 (Reuters) - Indian drugmaker Mankind Pharma reported a higher third-quarter profit on Tuesday, driven by strong ...

Novo Nordisk A/S’s chief executive officer asked investors to stick with him after a dire sales forecast caused a share price rout, saying a surge in prescriptions for cheaper obesity drugs will ...

The San Francisco-based drugmaker said Tuesday that it plans to double its investment and create an additional 100 jobs at a ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...

The Pharmaceutical Research and Manufacturers of America spent nearly $38 million on lobbying last year, the highest annual ...

Eli Lilly & Co. is the first pharmaceutical stock to hit a $1 trillion valuation, with its stock’s rise driven by a methodical approach to capturing an obesity-drug market that didn’t exist five years ...

Pfizer forecast modest 2026 guidance as it looks to counter waning Covid product sales and declines from older drugs with longer-term investments in its pipeline. The company expects adjusted profit ...